產(chǎn)品中心
產(chǎn)品詳情

  • 產(chǎn)品名稱：TSG101 抗原（重組蛋白）

  • 產(chǎn)品型號：100ug
  • 產(chǎn)品廠商：通蔚生物
  • 產(chǎn)品價格：800
  • 產(chǎn)品庫存：35
  • 產(chǎn)品文檔：
你添加了1件商品 查看購物車
簡單介紹：
我司 TSG101 抗原（重組蛋白）提供多達(dá)兩萬種產(chǎn)品，大部分現(xiàn)貨銷售，客戶關(guān)系管理系統(tǒng)和客戶關(guān)系管理團(tuán)隊，能**時間響應(yīng)售前、售后需求，關(guān)注客戶體驗及滿意度。為您提供專業(yè)、耐心的服務(wù)，歡迎廣大用戶來電來涵咨詢購買。
詳情介紹：

中文名稱： TSG101 抗原（重組蛋白）

英文名稱： TSG101 Antigen (Recombinant Protein)

別     名：  tumor susceptibility 101; TSG10; VPS23

儲     存：  冷凍（-20℃）

相關(guān)類別： 抗原

概     述：
 
Fusion protein corresponding to a region derived from 2-145 amino acids of human TSG101
   
技術(shù)規(guī)格

Full name:

tumor susceptibility 101

Synonyms:

TSG10; VPS23

Swissprot:

Q99816

Gene Accession:

BC002487

Purity:

>85%, as determined by Coomassie blue stained SDS-PAGE

Expression system:

Escherichia coli

Tags:

His tag C-Terminus, GST tag N-Terminus

Background:

The protein encoded by this gene belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. The gene product contains a coiled-coil domain that interacts with stathmin, a cytosolic phosphoprotein implicated in tumorigenesis. The protein may play a role in cell growth and differentiation and act as a negative growth regulator. In vitro steady-state expression of this tumor susceptibility gene appears to be important for maintenance of genomic stability and cell cycle regulation. Mutations and alternative splicing in this gene occur in high frequency in breast cancer and suggest that defects occur during breast cancer tumorigenesis and/or progression.





姓名：
電話：
您的需求：